INVESTIGATIONS ON THE DEVELOPMENT OF A DRAFT PHARMACOPOEIA ARTICLE ON YELLOW IRIS (IRIS PSEUDACORUS) RHIZOMES: CHARACTERISTICS OF IDENTITY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Yellow iris (Iris pseudacorus L.) is widespread in the Russian Federation. The plant has a complex multicomponent composition of biologically active substances. However, the use of yellow iris rhizomes is very limited in Russian officinal medicine. The wider use of yellow iris rhizomes as a pharmaceutical plant substance and the design of innovative drugs require regulatory documentation that meets the current requirements for medicinal plant raw materials. Objective: to conduct in-depth morphological and anatomical studies of yellow iris rhizomes for the subsequent development of the draft pharmacopoeia article (PA) «Yellow iris rhizomes» Material and methods. The dried yellow iris rhizomes stored in the Shatura District, Moscow Region, in the summer of 2015 were investigated. The appearance and anatomical structure of the rhizomes were analyzed using the methods laid down in the State Pharmacopoeia of the Russian Federation, 14th edition (SP 14). Results. The investigators provide a refined and extended description of the appearance of yellow iris rhizomes of different processing forms (the rhizomes can be left whole, grounded, or powdered). Microscopic analysis made it possible to clarify their diagnostic signs characterizing whole raw materials and to visualize them. Conclusion. The findings of the in-depth morphological and anatomical studies of yellow iris rhizomes, which revealed their diagnostic signs, can be used in the development of a draft PA for raw materials.

Full Text

Restricted Access

About the authors

Ekaterina Alekseevna Tikhomirova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: tekatal@rambler.ru
postgraduate Student, Department of Pharmaceutical Natural Science, Institute of Pharmacy Moscow, Russian Federation

Alla Anatolievna Sorokina

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: sor.alla2013@yandex.ru
professor Department of Pharmaceutical Natural Science, Institute of Pharmacy Moscow, Russian Federation

References

  1. Родионенко Г.И. Отаксономической структуре Iris pseudacorus L. (Iridaceae). Ботанический журнал, 2003; 5: 133-8.
  2. Kassak Pavol. Screening of the chemical content of several Limniris group Irise Ing. Journal of Pharmacognosy and Phytochemistry, 2014; 3 (2):11-4.
  3. Tarbeeva D.V., Fedoreev S.A., Veselova M.V. et al. Polyphenolic metabolites from Iris pseudacorus croots. Chemistryof Natural Compounds, 2015; 51 (3): 451-5.
  4. Тихомирова Е.А., Сорокина А.А. Ирис болотный: химический состав и фармакологические эффекты. Фармация, 2018; 66 (2): 9-14. https://doi.org/10.29296.25419218-2018-02-02
  5. Затыльникова О.А., Ковалев В.Н., Ковалев С.В. Компонентный состав эфирных масел Iris pseudacorus (Iridacea). Растительные ресурсы, 2013; 49 (2): 233.
  6. Затильнікова О.О., Ковальов С.В. Вивчення амінокислотного та мінерального складу підземних органів Iris pseudacorus L. Фармаком, 2009;1: 45-7.
  7. Хохлова Н.А., Деркач Н.В., Затыльникова О.В. и др. Фармакологическое изучение Iris pseudacorus. Украинский биофармацевтический журнал, 2012; 1-2: 18-9.
  8. Тихомирова Л.И. и др. Фармаколого-биохимическое обоснование практического использования некоторых представителей рода Iris L. Химия растительного сырья, 2015; 3: 25-34.
  9. Тихомирова Е.А., Сорокина А.А., Марахова А.И. Корневища ириса болотного: антимикробная активность. Фармация, 2017; 66 (7): 42-5.
  10. Саканян Е.И., Бунятян Н.Д., Сакаева И.В. и др. Современные подходы к структуре построения фармакопейных статей на лекарственное растительное сырье. Фармация, 2015; 4: 9-11.
  11. Государственная фармакопея РФ XIV изд. [Электронный ресурс]. Режим доступа: http://femb.ru/feml

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies